OTRIVIN MEDICATED COMPLETE NASAL CARE
Google image searchProduct monograph
Active ingredient
xylometazoline hydrochloride, 0.1 %/W/V
DIN: 02331403
Dosage form(s): SPRAY
Route(s) of administration: NASAL
Schedule: OTC
Company: HALEON CANADA ULC
Date: 03-MAY-2024
ATC:
- R01 — NASAL PREPARATIONS (ATC, ATC/DDD, )
- R01A — DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE (ATC, ATC/DDD)
- R01AA — Sympathomimetics, plain (ATC, ATC/DDD)
- R01AA07 — XYLOMETAZOLINE (ATC/DDD)
Reference brand drug: Otrivin
